Justin Page releases memoir on Spravato treatment

Musician and U.S. Presidential Scholar Justin Page has released Listening to Spravato, a memoir about his experience with esketamine treatment for severe depression. The book adds a firsthand perspective to the growing debate over ketamine-based mental health therapies and is available now online.

Why it matters: - Listening to Spravato offers a rare first-person account of Spravato treatment from inside the patient experience. - The memoir arrives as ketamine-based therapies move further into mainstream mental-health care. - Page’s perspective adds a creative lens to discussions about depression treatment, stigma and access.

What happened: - Author and musician Justin Page released Listening to Spravato in Montclair, New Jersey. - Page is a United States Presidential Scholar in the Arts. - The memoir focuses on Page’s experience undergoing Spravato, also known as esketamine, for severe depression. - The book is available now through major online retailers, including Amazon.

The details: - Page said the project began the day he returned home from his first Spravato session. - Page said the experience changed his perception so strongly that he felt compelled to document it. - Listening to Spravato combines raw honesty, humor and a musician’s attention to sound. - Page described the treatment as something he was “listening to” as much as experiencing. - The memoir is framed around the intersection of sound, healing and identity. - The release includes contact information for interviews, review copies and speaking engagements. - The listed media contact is Justin Page, with the email info@listenspravato.com.

Between the lines: - The book enters a market where psychedelic-adjacent treatments are gaining attention, but patient narratives remain limited. - Page’s musical background gives the memoir a distinct angle compared with standard illness memoirs. - The release positions the book as both a personal recovery story and a broader commentary on mental-health treatment.

What's next: - Page is available for interviews, review copies and speaking engagements. - The book may help shape conversation around how patients experience ketamine-based therapy and why firsthand accounts matter. - The release points to continued public interest in Spravato and similar treatments as psychiatry evolves.

The bottom line: - Listening to Spravato turns one musician’s treatment experience into a public-facing case study on depression, healing and the emotional texture of esketamine therapy.